Shiva Pharmachem IPO Details Today, GMP Price, Date, Review

Shiva Pharmachem IPO Details Today : Shiva Pharmachem IPO is Open on [.] 2024 and Close on [.] 2024. Shiva Pharmachem IPO to Raise [.] shares (Approx ₹[.] Cr) via IPO. The Fresh issue of [.] shares (Approx ₹[.] Cr).

Shiva Pharmachem offered over 100 specialized products.Our product lines include aliphatic and aromatic chlorides, aliphatic and aromatic nitriles, alkoxy ketones, herbicide safeners, thiocarbamates, chloroformatesand isocyanates. Our products have diversified applications across a number of industry sectors includingagrochemicals, performance materials, disinfectants, pharmaceuticals, polymers, cosmetics and others, which helps protect our business against downturns in a particular industry. We have also entered into a confidential disclosure agreement with a flavours and fragrance company in Europe relating to the custom synthesis business.

In addition, we are in the process of entering into a confidential disclosure agreementwith a global agrochemical company relating to the custom synthesis of two products, and weaim to commence production of these products. There are strong and sustainable entry barriers in manufacturing our chemical products which include our technology, our complexchemistries, our backward integration of most of our products, our transportation and storage capabilities in India and Europe, our diverse customer base and our large scale operations. Shiva Pharmachem have over 20 years of experience in the Indian specialty chemicals business. Initially, we started our operations with chlorine chemistry as our core competency with a focus on chlorination of acid and alcohols by thionyl chloride.

We subsequently developed competencies in advanced intermediates involving complex chemistry and multi-step processes (typically4 to 5 steps). We manufacture our products atour facilities in Luna (Gujarat), Dahej SEZ(Gujarat) we are backward integrated for most of our key products. We are experienced in handling hazardous chemistries (like chlorination and vapour phase reactions at high temperatures of 400 ºC and above) and, through our R&D team we have developed in-house technology for all of ourproducts including bulk acid chlorides and specialty chemicalsthat hasenabled us to enjoy strategic positioning amongst our reputed customers. Our customer base is diverse, and we served 181 multinational and domesticcompanies in Fiscal 2023. we soldour products to 22 countries outside India. Some of the key geographies in which we sell our products include Germany, the United States, Switzerland, Italy and Mexico.

Object of the Issue

1. Carry out the Offer for Sale of up to [●] Equity Shares aggregating up to ₹ 9,000.00 million by the Selling Shareholders.
2. Achieve the benefits of listing the Equity Shares on the Stock Exchanges.

Our Company Promoter

1. Rakesh Shiwebhagwan Agrawal
2. Vishal Rakesh Agrawal
3. Rahul Rakesh Agrawal
4. Rakesh Agrawal Family Trust
5. Vishal Agrawal Family Trust 
6. Rahul Agrawal Family Trust

Qualitative Factors

1. Leading player across several specialty chemical products with significant industry barriers.
2. Focus on R&D and technology, automation and innovation.
3. Diversified, global customer base with longstanding relationships.
4. Strategically located manufacturing facilities and well-connected logistics infrastructure.
5. Emphasis on sustainability through company-wide focus on environment, health and safety.
6. Strong and consistent financial performance.
7. Experienced Promoters and strong Board and management team.

Comparison of accounting ratios with listed industry peers

1. Shiva Pharmachem Limited
2. Navin Flourine International Limited
3. Clean Science and Technology Limited
4. Aether Industries Limited

Shiva Pharmachem Company Contact Details

12thFloor, SHIVA,
Sarabhai Complex, Dr. Vikram Sarabhai Marg,
Vadiwadi, Vadodara-390 023, Gujarat, India
Telephone:+91 265 2335432
Email: shivacs@shivapharmachem.com
Webiste: www.shivapharmachem.com

Shiva Pharmachem IPO Registrar

Link Intime India PrivateLimited
C-101, 1stFloor, 247 Park
L.B.S. Marg, Vikhroli (West)
Mumbai –400083, Maharashtra, India
Telephone: +91 810 811 4949
E-mail: shivapharmachem.ipo@linkintime.co.in
Investor grievance E-mail:shivapharmachem.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact person: Shanti Gopalkrishnan